Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 2

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 9Venous Thromboembolism 8Venous Thrombosis 7Pulmonary Embolism 5Thrombosis 4Pancreatic Neoplasms 4Thromboembolism 3Lymphoma 3Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Hemorrhage 2Carcinoma, Non-Small-Cell Lung 2Venous Thormboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Stroke 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Tranexamic Acid 12Sodium Chloride 4Misoprostol 4Saline Solution 3carbetocin 2Tourniquets 2Oxytocin 2Enoxaparin 2Endoscopic Mucosal Resection 2Dalteparin 2Vitamin B 6 1Vasopressins 1Uterine Artery Embolization 1Ultrasonography 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surveys and Questionnaires 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Lactate 1Radiotherapy 1Pancreaticoduodenectomy 1Palliative Care 1Neuromuscular Blockade 1N(4)-oleylcytosine arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hemorrhage × Enoxaparin × Clear all
NCT04731558 2025-02-14

PREPOSTEROUS

Helsinki University Central Hospital

Phase 4 Recruiting
1,012 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Pulmonary Embolism, Venous Thrombosis

NCT05245877 2025-02-14

PREPOSTEROUS2

Helsinki University Central Hospital

Phase 4 Recruiting
800 enrolled
Gastrointestinal

Hemorrhage, Pancreatic Neoplasms, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡